Immutep Stock (NASDAQ: IMMP) stock price, news, charts, stock research, profile.
Open | $2.780 |
Close | $2.820 |
Volume / Avg. | 315.670K / 190.479K |
Day Range | 2.730 - 2.890 |
52 Wk Range | 1.500 - 3.900 |
Market Cap | $326.930M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | - |
Days to Cover | 13.97 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immutep (NASDAQ: IMMP) through any online brokerage.
Other companies in Immutep’s space includes: Skye Bioscience (NASDAQ:SKYE), CytomX Therapeutics (NASDAQ:CTMX), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for Immutep (NASDAQ: IMMP) was reported by Baird on Monday, August 28, 2023. The analyst firm set a price target for 7.00 expecting IMMP to rise to within 12 months (a possible 154.55% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Immutep (NASDAQ: IMMP) is $2.75 last updated May 3, 2024 at 5:11 PM EDT.
There are no upcoming dividends for Immutep.
Immutep’s H1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Immutep.
Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.